FOXO1 and B-cell chronic lymphocytic leukemia: We show that the FoxO1/Rictor/pAktS473 axis is induced during ibrutinib treatment, and this helps CLL cells adapt and survive in peripheral blood, which associates with the extent of lymphocytosis following the treatment initiation.